BioCentury
ARTICLE | Financial News

BioPharmX completes $5M registered direct offering

May 2, 2017 12:29 AM UTC

Dermatology company BioPharmX Corp. (NYSE-M:BPMX) raised $5 million through the sale of 6.4 million shares at $0.78 in a registered direct offering on April 28. Roth Capital Partners was the placement...

BCIQ Company Profiles

Timber Pharmaceuticals LLC